Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Radiation Injuries 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Cholangiocarcinoma 1 Cervical Cancer Susceptible Population Classification 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 49 Carboplatin 44 Magnetic Resonance Spectroscopy 40 Specimen Handling 39 Pemetrexed 34 Cisplatin 25 Blood Specimen Collection 25 durvalumab 17 Paclitaxel 16 osimertinib 15 Radiotherapy 15 Radiosurgery 15 Bevacizumab 15 Gemcitabine 14 atezolizumab 13 Nivolumab 13 Biopsy 13 Drug Therapy 12 Standard of Care 10 Practice Guidelines as Topic 10 Immunoglobulin G 10 Docetaxel 10 130-nm albumin-bound paclitaxel 10 X-Rays 9 Taxes 9 Educational Status 9 Disulfides 9 tislelizumab 8 Etoposide 8 Cetuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Base Sequence × Clear all

NCT06659458 2025-03-20

EGFR Lung Canc

Our Lady of the Lake Hospital

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡